Pharmaceutical Information |
Drug Name |
Chlorzoxazone |
Drug ID |
BADD_D00449 |
Description |
A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202) |
Indications and Usage |
For the relief of discomfort associated with acute painful musculoskeletal conditions. |
Marketing Status |
approved |
ATC Code |
M03BB03 |
DrugBank ID |
DB00356
|
KEGG ID |
D00771
|
MeSH ID |
D002753
|
PubChem ID |
2733
|
TTD Drug ID |
D08ZEB
|
NDC Product Code |
13811-717; 16571-726; 0254-2053; 42494-426; 0254-2005; 53002-5760; 55700-951; 60760-479; 69499-330; 59651-306; 50090-0315; 55289-633; 71335-2009; 63629-1586; 70954-085; 71205-711; 72319-168; 0591-2520; 46016-9522; 58159-030; 76055-0034; 45865-434; 80425-0315; 70966-0019; 68025-046; 16571-725; 42494-425; 52817-230; 61919-478; 68025-047; 72319-169; 60760-619; 63629-9158; 43235-0005; 52817-231; 60760-578; 71335-1914; 51862-339; 63187-317; 54871-0001; 13811-718; 16571-727; 24470-923; 42494-428 |
UNII |
H0DE420U8G
|
Synonyms |
Chlorzoxazone | Parafon | Parafon Forte DSC | Paraflex |
|
Chemical Information |
Molecular Formula |
C7H4ClNO2 |
CAS Registry Number |
95-25-0 |
SMILES |
C1=CC2=C(C=C1Cl)NC(=O)O2 |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|